Proven Executive Brings 17 Years of Experience in Scaling Leading Healthcare Businesses
BASKING RIDGE, N.J.—November 1, 2023 – IVI RMA America, the North American business of IVI RMA, the largest reproductive medicine group in the world, today announced the appointment of Lynn Mason as Chief Executive Officer. She will oversee the North American operations as well as growth initiatives in support of bringing better fertility outcomes to more patients across the United States and Canada.
“Lynn is a talented, proven leader who has made her mark on the ever-changing healthcare environment by working as a transformative executive in both large and small organizations, delivering quality care and a great patient experience,” said Javier Sanchez Prieto, CEO of IVI RMA. “We’re excited for Lynn’s leadership as we continue to foster a patient-first approach while delivering industry-leading fertility solutions.”
Prior to joining IVI RMA America, Mason served for four years as President and Chief Executive Officer of Broadstep Behavioral Health, a leading provider of behavioral health and supportive living services for children and adults with intellectual and developmental disabilities, mental illness, and co-occurring disorders. During her tenure at Broadstep, the company more than doubled in size in three years, expanding from four to seven states. Earlier in her career, Mason held senior leadership roles with increasing responsibility in healthcare organizations, including ChenMed, Care Services, DaVita Kidney Care and DaVita RX, and United Allergy Services.
Mason currently serves on the Boards of Directors of nonprofits Shoes-That-Fit and the American Heart Association-Go Red for Women. She also contributes to primary care and behavioral health by serving on the Board of Directors for ConvenientMD and Stella Behavioral Health and is an active member of the Stanford Women on Boards and The Stanford Black Alumni Association.
Mason earned her BSBA degree in Finance and Accounting from Washington University in St. Louis and her MBA from Stanford University’s Graduate School of Business.
“IVI RMA has a stellar reputation for the industry’s best outcomes, most innovative R&D platform, and sharpest talent, and I am thrilled and honored to join as CEO for America,” said Mason. “I’m eager to support our physician leaders in expanding our presence and strengthening our culture to make IVI RMA America the natural first choice for patients, physicians, and medical partners.”
“The team and I look forward to Lynn bringing a fresh and energized perspective to our business and complementing our scientific leaders,” added Thomas A. Molinaro, M.D., Medical Director, IVI RMA America. “Her experience across multiple channels of healthcare delivery will serve us well as we position the organization for future growth and continued reproductive excellence.”
About IVI RMA
IVI RMA is the world’s leading Reproductive Medicine group. It is committed to providing evidence-based fertility solutions with the greatest chance of success in the shortest time necessary to patients seeking treatment anywhere in the world. IVI RMA employs nearly 3,900 people across +150 locations in 14 countries. The group maintains a team of highly trained physicians as well as renowned scientists and researchers, aligned with its vision of pioneering in the field of Reproductive Medicine.
